Clinical trial: CRISPR therapy for sickle cell disease – Innovative Genomics Institute (IGI),

After six years of work, that experimental treatment has now been approved for clinical trials by the U.S. Food and Drug Administration, enabling the first …, After six years of work, that experimental treatment has now been approved for clinical trials by the U.S. Food and Drug Administration, enabling the first …, Read More

Scroll to Top